Literature DB >> 30603891

Predictors of ventricular ablation's success: Viability, innervation, or mismatch?

Alessia Gimelli1, Francesca Menichetti2,3, Ezio Soldati2, Riccardo Liga2, Nicola Scelza2, Giulio Zucchelli2, Andrea Di Cori2, Luca Segreti2, Andrea Vannozzi2, Maria Grazia Bongiorni2, Paolo Marzullo4,5.   

Abstract

AIMS: Sympathetic dys-innervation may play an important role in the development of post-ischemic ventricular arrhythmias (VA). Aim of this study was to prove that perfusion/innervation mismatch (PIM) evaluated by SPECT can identify areas of local abnormal ventricular activities (LAVA) on electroanatomic mapping (EAM).
METHODS: Sixteen patients referred to post-ischemic VA catheter ablation underwent pre-procedural and 1-month post-ablation 123I-MIBG/99mTc-tetrofosmin rest SPECT myocardial imaging. PIM was defined according to the segmental distributions of 99mTc-tetrofosmin and 123I-MIBG. A 17-segment LV analysis was used for either SPECT or LV EAM voltage map. All patients were followed up clinically for at least 1 year.
RESULTS: Before ablation, the mean voltage in the PIM segments was higher than in the scarred ones but lower than in the normal regions. The presence of PIM in a specific LV zone was an independent predictor of LAVA. After ablation, PIM value was significantly reduced, mainly due to an increase in perfusion summed rest score, in particular in patients that were responders to ablation.
CONCLUSIONS: PIM may associate with VA substrate expressed by LAVA and might provide a novel guide for substrate ablation. A significant reduction of PIM could predict a positive clinical response to ablation.

Entities:  

Keywords:  Intervention tracers; cardiac innervation; diagnostic and prognostic application; image-guided application; multimodality

Mesh:

Substances:

Year:  2019        PMID: 30603891     DOI: 10.1007/s12350-018-01575-x

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  2 in total

1.  Outcome of catheter ablation for ventricular tachycardia in patients with ischemic cardiomyopathy: A systematic review and meta-analysis of randomized clinical trials.

Authors:  Waddah Maskoun; Marwan Saad; Amjad Abualsuod; Ramez Nairooz; John M Miller
Journal:  Int J Cardiol       Date:  2018-04-08       Impact factor: 4.164

2.  Long-Term Outcome of Substrate Modification in Ablation of Post-Myocardial Infarction Ventricular Tachycardia.

Authors:  Michael Wolf; Frédéric Sacher; Hubert Cochet; Takeshi Kitamura; Masateru Takigawa; Seigo Yamashita; Konstantinos Vlachos; Ghassen Cheniti; Antonio Frontera; Ruairidh Martin; Nathaniel Thompson; Grégoire Massoullié; Anna Lam; Claire Martin; Florent Collot; Josselin Duchateau; Thomas Pambrun; Arnaud Denis; Nicolas Derval; Mélèze Hocini; Michel Haïssaguerre; Pierre Jaïs
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.